-
-
Until a year ago, the treatment of Hepatitis was extremely costly and ineffective. However, the situation changed slightly with the introduction of Sofosbuvir owned by Gilead, a US-based medicine manufacturer. But the cost at which the medicine is available is still out of reach for many people.
Gilead knows that in developing countries there are 103 million people living with hepatitis C, and for this it has engaged with 11 India-based generic pharmaceutical manufacturers to develop and sale Sofosbuvir, a drug used to treat Hepatitis C. “Natco Pharma Ltd” is one of those manufacturing companies.
NATCO living up to its purpose of “Making speciality medicines accessible to all” has launched generic brand HEPCINAT (Sofosbuvir), a package of 28 tablets that works astonishingly well to treat people with the liver disease Hepatitis C.
The company got the approval for the production and distribute of chronic Hepatitis C medicine which is called Natco Hepcinat LP. This medicine is helpful for people suffering from chronic Hepatitis C genotype infection. Chronic hepatitis c may increase the risk of liver failure. Generally the treatment cost of hep c is very high. The generic version of US hep c medicines price in India is affordable. Read more.
-
You must be logged in to post a comment.